Literature DB >> 20225221

Basal ganglia hypoactivity during grip force in drug naïve Parkinson's disease.

Matthew B Spraker1, Janey Prodoehl, Daniel M Corcos, Cynthia L Comella, David E Vaillancourt.   

Abstract

The basal ganglia (BG) are impaired in Parkinson's disease (PD), but it remains unclear which nuclei are impaired during the performance of motor tasks in early-stage PD. Therefore, this study was conducted to determine which nuclei function abnormally, and whether cortical structures are also affected by early-stage PD. The study also determined if cerebellar hyperactivity is found early in the course of PD. Blood oxygenation level dependent activation was compared between 14 early-stage drug-naïve PD patients and 14 controls performing two precision grip force tasks using functional magnetic resonance imaging at 3 T. The grip tasks used in this study were chosen because both tasks are known to provide robust activation in BG nuclei, and the two tasks were similar except that the 2-s task required more switching between contraction and relaxation than the 4-s task. The 4-s task revealed that PD patients were hypoactive relative to controls only in putamen and external globus pallidus, and thalamus. In the 2-s task, PD patients were hypoactive throughout all BG nuclei, thalamus, M1, and supplementary motor area. There were no differences in cerebellar activation between groups during either task. Regions of interest analysis revealed that the hypoactivity observed in PD patients during the 2-s task became more pronounced over time as patients performed the task. This suggests that a motor task that requires switching can accentuate abnormal activity throughout all BG nuclei of early-stage, drug-naive PD, and that the abnormal activity becomes more pronounced with repeated task performance in these patients.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20225221      PMCID: PMC6870615          DOI: 10.1002/hbm.20987

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  33 in total

1.  What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. 1992.

Authors:  A J Hughes; Y Ben-Shlomo; S E Daniel; A J Lees
Journal:  Neurology       Date:  2001-11       Impact factor: 9.910

2.  Metabolic correlates of pallidal neuronal activity in Parkinson's disease.

Authors:  D Eidelberg; J R Moeller; K Kazumata; A Antonini; D Sterio; V Dhawan; P Spetsieris; R Alterman; P J Kelly; M Dogali; E Fazzini; A Beric
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

3.  Neural basis for the processes that underlie visually guided and internally guided force control in humans.

Authors:  David E Vaillancourt; Keith R Thulborn; Daniel M Corcos
Journal:  J Neurophysiol       Date:  2003-07-02       Impact factor: 2.714

Review 4.  Assessment of the progression of Parkinson's disease: a metabolic network approach.

Authors:  Thomas Eckert; Chengke Tang; David Eidelberg
Journal:  Lancet Neurol       Date:  2007-10       Impact factor: 44.182

5.  Effects of increased stroke number on sequential arm movements in Parkinson's disease subjects.

Authors:  M K Rand; G E Stelmach
Journal:  Parkinsonism Relat Disord       Date:  1999-04       Impact factor: 4.891

6.  Injection of GABA-agonist into globus pallidus in patient with Parkinson's disease.

Authors:  R D Penn; J S Kroin; A Reinkensmeyer; D M Corcos
Journal:  Lancet       Date:  1998-01-31       Impact factor: 79.321

7.  A functional MRI study of automatic movements in patients with Parkinson's disease.

Authors:  Tao Wu; Mark Hallett
Journal:  Brain       Date:  2005-06-15       Impact factor: 13.501

8.  Reduction in external cues and movement sequencing in Parkinson's disease.

Authors:  N Georgiou; J L Bradshaw; R Iansek; J G Phillips; J B Mattingley; J A Bradshaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

9.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

10.  Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.

Authors:  Andrew Feigin; Michael G Kaplitt; Chengke Tang; Tanya Lin; Paul Mattis; Vijay Dhawan; Matthew J During; David Eidelberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

View more
  38 in total

1.  Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease.

Authors:  Janey Prodoehl; Mathew Spraker; Daniel Corcos; Cynthia Comella; David Vaillancourt
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

2.  Functional neuroimaging of motor control in Parkinson's disease: a meta-analysis.

Authors:  Damian M Herz; Simon B Eickhoff; Annemette Løkkegaard; Hartwig R Siebner
Journal:  Hum Brain Mapp       Date:  2013-10-05       Impact factor: 5.038

3.  Sensory and motor cortex function contributes to symptom severity in spinocerebellar ataxia type 6.

Authors:  Nyeonju Kang; Evangelos A Christou; Roxana G Burciu; Jae Woo Chung; Jesse C DeSimone; Edward Ofori; Tetsuo Ashizawa; Sankarasubramon H Subramony; David E Vaillancourt
Journal:  Brain Struct Funct       Date:  2016-06-28       Impact factor: 3.270

4.  Functional activity of the sensorimotor cortex and cerebellum relates to cervical dystonia symptoms.

Authors:  Roxana G Burciu; Christopher W Hess; Stephen A Coombes; Edward Ofori; Priyank Shukla; Jae Woo Chung; Nikolaus R McFarland; Aparna Wagle Shukla; Michael S Okun; David E Vaillancourt
Journal:  Hum Brain Mapp       Date:  2017-06-08       Impact factor: 5.038

5.  Parkinson's disease biomarkers program brain imaging repository.

Authors:  Edward Ofori; Guangwei Du; Debra Babcock; Xuemei Huang; David E Vaillancourt
Journal:  Neuroimage       Date:  2015-05-12       Impact factor: 6.556

6.  Brain activity during complex imagined gait tasks in Parkinson disease.

Authors:  Daniel S Peterson; Kristen A Pickett; Ryan P Duncan; Joel S Perlmutter; Gammon M Earhart
Journal:  Clin Neurophysiol       Date:  2013-11-05       Impact factor: 3.708

7.  A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease.

Authors:  Daniel M Corcos; Julie A Robichaud; Fabian J David; Sue E Leurgans; David E Vaillancourt; Cynthia Poon; Miriam R Rafferty; Wendy M Kohrt; Cynthia L Comella
Journal:  Mov Disord       Date:  2013-03-27       Impact factor: 10.338

8.  Subthalamic nucleus--sensorimotor cortex functional connectivity in de novo and moderate Parkinson's disease.

Authors:  Ajay S Kurani; Rachael D Seidler; Roxana G Burciu; Cynthia L Comella; Daniel M Corcos; Michael S Okun; Colum D MacKinnon; David E Vaillancourt
Journal:  Neurobiol Aging       Date:  2014-07-11       Impact factor: 4.673

9.  Functional Brain Activity Relates to 0-3 and 3-8 Hz Force Oscillations in Essential Tremor.

Authors:  Kristina A Neely; Ajay S Kurani; Priyank Shukla; Peggy J Planetta; Aparna Wagle Shukla; Jennifer G Goldman; Daniel M Corcos; Michael S Okun; David E Vaillancourt
Journal:  Cereb Cortex       Date:  2014-06-24       Impact factor: 5.357

10.  Differences in brain activation between tremor- and nontremor-dominant Parkinson disease.

Authors:  Janey Prodoehl; Peggy J Planetta; Ajay S Kurani; Cynthia L Comella; Daniel M Corcos; David E Vaillancourt
Journal:  JAMA Neurol       Date:  2013-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.